tiprankstipranks
Elevation Oncology presents positive Phase 1 results of EO-3021 combination
PremiumThe FlyElevation Oncology presents positive Phase 1 results of EO-3021 combination
1M ago
Elevation Oncology’s Q3 2024 Highlights and Financial Report
Premium
Company Announcements
Elevation Oncology’s Q3 2024 Highlights and Financial Report
2M ago
Elevation Oncology reports Q3 EPS (22c), consensus (20c)
Premium
The Fly
Elevation Oncology reports Q3 EPS (22c), consensus (20c)
2M ago
Elevation Oncology to evaluate combination in gastroesophageal junction cancer
PremiumThe FlyElevation Oncology to evaluate combination in gastroesophageal junction cancer
7M ago
Elevation Oncology initiated with an Overweight at Piper Sandler
Premium
The Fly
Elevation Oncology initiated with an Overweight at Piper Sandler
8M ago
Elevation Oncology initiated with an Overweight at Stephens
Premium
The Fly
Elevation Oncology initiated with an Overweight at Stephens
8M ago
Elevation Oncology presents preclinical proof-of concept data for HER3-ADC
PremiumThe FlyElevation Oncology presents preclinical proof-of concept data for HER3-ADC
9M ago
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
Premium
Company Announcements
Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
10M ago
Four new option listings on March 20th
Premium
The Fly
Four new option listings on March 20th
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100